IBA – Transparency Notification
21 Dezember 2023 - 6:00PM
IBA – Transparency Notification
IBA – TRANSPARENCY
NOTIFICATION
(Article 14, paragraph 1 of the law of 2
May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, December 21,
2023 18:00
Summary of the notification
IBA (Ion Beam Applications), the world’s leading
provider of proton therapy solutions for the treatment of cancer,
announces that it has to issue a transparency notification, in
accordance with Article 14, al. 1 of the Transparency Law of May 2,
2007 on disclosure of major holdings, further to the notification
received on December 18th 2023.
In its notification, NORGES BANK indicated that
following an acquisition or disposal of securities or voting
rights, its total shareholding in IBA SA had increased and its
shareholding in IBA shares with voting rights had crossed the
threshold of 2% on 14/12/2023.
Content of the notification
- Reason for the notification: Acquisition or disposal of
securities or voting rights
- Notification by: A person notifying alone
- Persons subject to the notification
requirement:
- Date on which the threshold is crossed: 14/12/2023
- Threshold crossed (in %) : 2%
- Denominator : 40.595.290
- Notified details: (extract of the received notification
form)
Norges Bank is the central bank of Norway. As
part of its central bank activities, Norges Bank manages Norway's
foreign exchange reservesand is responsible for management of the
Norwegian Government Pension Fund Global (GPFG). The formal
responsibility for managementof the GPFG is placed with the
Ministry of Finance, but is delegated to Norges Bank. All
investments are executed by Norges Bank acting asprincipal and all
holdings are registered in the name of Norges Bank.
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 2.000 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).More
information can be found at: www.iba-worldwide.com
For further information, please
contact:
Valérie Van
ImpeParalegal
+32479267809legal@iba-group.com
- 20231221-IBA-Norges Bank_transparency EN_14122023
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024